Myrtelle
Jenna Barton's work experience includes holding the role of Senior Vice President, Finance at Myrtelle since August 2021. Prior to that, they were the Sr. Director, FP&A at Black Diamond Therapeutics from 2020 to 2021. From 2015 to 2020, Jenna worked at Sage Therapeutics, first as the Director, R&D Finance and then as the Associate Director, Financial Planning & Analysis. Before that, they held various roles at Biogen, including Associate Director, Finance Technology and Business Operations, and Sr. Manager, Business Planning. Jenna's earlier experience includes working as the Manager, Market Intelligence and Pricing at Philips and as the Manager, Finance at Lonza.
Jenna Barton obtained a Post Graduate degree in Clinical and Commercial Drug Development from Tufts University in the year 2020. Prior to this, Jenna pursued a Bachelor of Science (BS) degree in Finance from the UNH Peter T. Paul College of Business and Economics. Additionally, Jenna has not specified the start and end years, but they pursued an MBA degree in Management and Finance from Suffolk University - Sawyer Business School.
This person is not in any teams
This person is not in any offices
Myrtelle
Myrtelle is a gene therapy company that offers clinical trials for the treatment of rare monogenetic disorders. It helps in addressing an array of diseases with white matter involvement that includes demyelinating diseases and ASPA-associated disorders with rare CNS diseases. It also helps healthcare professionals to develop and deliver noveltreatments for devastating disorders of the central nervous system and transform the treatment of neurological diseases that improve the quality of life and longevity.The company's mission is to develop and deliver novel treatments for devastating disorders of the central nervous system, beginning with its lead program, gene therapy treatment for Canavan disease.It was founded in 2020 and is headquartered in Wakefield, Massachusetts.